Endoplasmic reticulum vacuolation and unfolded protein response leading to paraptosis like cell death in cyclosporine A treated cancer cervix cells is mediated by cyclophilin B inhibition

Biochimica et Biophysica Acta - Molecular Cell Research

Volumn 1843, Issue 11, 2014, Pages 2497-2512

  Ram, Babul Moni ^a   Ramakrishna, Gayatri ^a,b  

^a CENTRE FOR DNA FINGERPRINTING AND DIAGNOSTICS   (India)

^b INSTITUTE OF LIVER AND BILIARY SCIENCES   (India)

Author keywords

Calcineurin; Cyclophilin B; Cyclosporine A; ER stress; Paraptosis

Indexed keywords

CYCLOHEXIMIDE; CYCLOPHILIN B; CYCLOSPORIN A; GLUCOSE REGULATED PROTEIN 78; PROTEIN IRE1; SALUBRINAL; SMALL INTERFERING RNA; TACROLIMUS;

APOPTOSIS; ARTICLE; CANCER CELL; CANCER INHIBITION; CELL DEATH; CELL VACUOLE; CONTROLLED STUDY; DRUG CYTOTOXICITY; ENDOPLASMIC RETICULUM; ENDOPLASMIC RETICULUM STRESS; ENZYME INHIBITION; FEMALE; GENE EXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; NICK END LABELING; PRIORITY JOURNAL; UNFOLDED PROTEIN RESPONSE; UTERINE CERVIX CANCER;

EID: 84905379809     PISSN: 01674889     EISSN: 18792596     Source Type: Journal    
DOI: 10.1016/j.bbamcr.2014.06.020     Document Type: Article

References (63)

1. Liu J., Farmer J.D., Lane W.S., Friedman J., Weissman I., Schreiber S.L. Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes. Cell 1991, 66:807-815.
2. Rao A., Luo C., Hogan P.G. Transcription factors of the NFAT family: regulation and function. Annu. Rev. Immunol. 1997, 15:707-747.
3. Kim Y., Lee Y.I., Seo M., Kim S.Y., Lee J.E., Youn H.D., Kim Y.S., Juhnn Y.S. Calcineurin dephosphorylates glycogen synthase kinase-3 beta at serine-9 in neuroblast-derived cells. J. Neurochem. 2009, 111:344-354.
4. Huang C.C., Wang J.M., Kikkawa U., Mukai H., Shen M.R., Morita I., Chen B.K., Chang W.C. Calcineurin-mediated dephosphorylation of c-Jun Ser-243 is required for c-Jun protein stability and cell transformation. Oncogene 2008, 27:2422-2429.
5. 2+-induced apoptosis through calcineurin dephosphorylation of BAD. Science 1999, 284:339-343.
6. Drewes G., Mandelkow E.M., Baumann K., Goris J., Merlevede W., Mandelkow E. Dephosphorylation of tau protein and Alzheimer paired helical filaments by calcineurin and phosphatase-2A. FEBS Lett. 1993, 336:425-432.
7. Baksh S., DeCaprio J.A., Burakoff S.J. Calcineurin regulation of the mammalian G0/G1 checkpoint element, cyclin dependent kinase 4. Oncogene 2000, 19:2820-2827.
8. Marks B., McMahon H.T. Calcium triggers calcineurin-dependent synaptic vesicle recycling in mammalian nerve terminals. Curr. Biol. 1998, 8:740-749.
9. Davis T.L., Walker J.R., Campagna-Slater V., Finerty P.J., Paramanathan R., Bernstein G., MacKenzie F., Tempel W., Ouyang H., Lee W.H., Eisenmesser E.Z., Dhe-Paganon S. Structural and biochemical characterization of the human cyclophilin family of peptidyl-prolyl isomerases. PLoS Biol. 2010, 8:e1000439.
10. Fry L. Psoriasis: immunopathology and long-term treatment with cyclosporin. J. Autoimmun. 1992, 5(Suppl. A):277-283.
11. Flytstrom I., Stenberg B., Svensson A., Bergbrant I.M. Methotrexate vs. ciclosporin in psoriasis: effectiveness, quality of life and safety. A randomized controlled trial. Br. J. Dermatol. 2008, 158:116-121.
12. Molkentin J.D., Lu J.R., Antos C.L., Markham B., Richardson J., Robbins J., Grant S.R., Olson E.N. A calcineurin-dependent transcriptional pathway for cardiac hypertrophy. Cell 1998, 93:215-228.
13. Tedesco D., Haragsim L. Cyclosporine: a review. Am. J. Transplant. 2012, 2012:230386.
14. Euvrard S., Kanitakis J., Decullier E., Butnaru A.C., Lefrancois N., Boissonnat P., Sebbag L., Garnier J.L., Pouteil-Noble C., Cahen R., Morelon E., Touraine J.L., Claudy A., Chapuis F. Subsequent skin cancers in kidney and heart transplant recipients after the first squamous cell carcinoma. Transplantation 2006, 81:1093-1100.
15. Xiao Z., Li C., Shan J., Luo L., Feng L., Lu J., Li S., Long D., Li Y. Mechanisms of renal cell apoptosis induced by cyclosporine A: a systematic review of in vitro studies. Am. J. Nephrol. 2011, 33:558-566.
16. Nakagawa T., Shimizu S., Watanabe T., Yamaguchi O., Otsu K., Yamagata H., Inohara H., Kubo T., Tsujimoto Y. Cyclophilin D-dependent mitochondrial permeability transition regulates some necrotic but not apoptotic cell death. Nature 2005, 434:652-658.
17. Seaton T.A., Cooper J.M., Schapira A.H. Cyclosporin inhibition of apoptosis induced by mitochondrial complex I toxins. Brain Res. 1998, 809:12-17.
18. Walter D.H., Haendeler J., Galle J., Zeiher A.M., Dimmeler S. Cyclosporin A inhibits apoptosis of human endothelial cells by preventing release of cytochrome C from mitochondria. Circulation 1998, 98:1153-1157.
19. Pritchard D.E., Singh J., Carlisle D.L., Patierno S.R. Cyclosporin A inhibits chromium(VI)-induced apoptosis and mitochondrial cytochrome c release and restores clonogenic survival in CHO cells. Carcinogenesis 2000, 21:2027-2033.
20. Raymond M.A., Mollica L., Vigneault N., Desormeaux A., Chan J.S., Filep J.G., Hebert M.J. Blockade of the apoptotic machinery by cyclosporin A redirects cell death toward necrosis in arterial endothelial cells: regulation by reactive oxygen species and cathepsin D. FASEB J. 2003, 17:515-517.
21. Halestrap A.P., Connern C.P., Griffiths E.J., Kerr P.M. Cyclosporin A binding to mitochondrial cyclophilin inhibits the permeability transition pore and protects hearts from ischaemia/reperfusion injury. Mol. Cell. Biochem. 1997, 174:167-172.
22. Hojo M., Morimoto T., Maluccio M., Asano T., Morimoto K., Lagman M., Shimbo T., Suthanthiran M. Cyclosporine induces cancer progression by a cell-autonomous mechanism. Nature 1999, 397:530-534.
23. Xu J., Walsh S.B., Verney Z.M., Kopelovich L., Elmets C.A., Athar M. Procarcinogenic effects of cyclosporine A are mediated through the activation of TAK1/TAB1 signaling pathway. Biochem. Biophys. Res. Commun. 2011, 408:363-368.
24. Zupanska A., Dziembowska M., Ellert-Miklaszewska A., Gaweda-Walerych K., Kaminska B. Cyclosporine a induces growth arrest or programmed cell death of human glioma cells. Neurochem. Int. 2005, 47:430-441.
25. Jiang K., He B., Lai L., Chen Q., Liu Y., Guo Q., Wang Q. Cyclosporine A inhibits breast cancer cell growth by downregulating the expression of pyruvate kinase subtype M2. Int. J. Mol. Med. 2012, 30:302-308.
26. Rafferty P., Egenolf D., Brosnan K., Makropoulos D., Jordan J., Meshaw K., Walker M., Volk A., Bugelski P.J. Immunotoxicologic effects of cyclosporine on tumor progression in models of squamous cell carcinoma and B-cell lymphoma in C3H mice. J. Immunotoxicol. 2012, 9:43-55.
27. Kurz D.J., Decary S., Hong Y., Erusalimsky J.D. Senescence-associated (beta)-galactosidase reflects an increase in lysosomal mass during replicative ageing of human endothelial cells. J. Cell Sci. 2000, 113(Pt 20):3613-3622.
28. Kapuscinski J., Darzynkiewicz Z., Melamed M.R. Interactions of acridine orange with nucleic acids. Properties of complexes of acridine orange with single stranded ribonucleic acid. Biochem. Pharmacol. 1983, 32:3679-3694.
29. 2+. J. Biol. Chem. 1995, 270:18051-18059.
30. Schrag J.D., Bergeron J.J., Li Y., Borisova S., Hahn M., Thomas D.Y., Cygler M. The Structure of calnexin, an ER chaperone involved in quality control of protein folding. Mol. Cell 2001, 8:633-644.
31. Boyce M., Bryant K.F., Jousse C., Long K., Harding H.P., Scheuner D., Kaufman R.J., Ma D., Coen D.M., Ron D., Yuan J. A selective inhibitor of eIF2alpha dephosphorylation protects cells from ER stress. Science 2005, 307:935-939.
32. Hovland A.R., La Rosa F.G., Hovland P.G., Cole W.C., Kumar A., Prasad J.E., Prasad K.N. Cyclosporin A regulates the levels of cyclophilin A in neuroblastoma cells in culture. Neurochem. Int. 1999, 35:229-235.
33. Carpentier M., Allain F., Haendler B., Slomianny M.C., Spik G. Delineation of the calcineurin-interacting region of cyclophilin B. Protein Sci. 2000, 9:2386-2393.
34. Sperandio S., de Belle I., Bredesen D.E. An alternative, nonapoptotic form of programmed cell death. Proc. Natl. Acad. Sci. U. S. A. 2000, 97:14376-14381.
35. Sperandio S., Poksay K., de Belle I., Lafuente M.J., Liu B., Nasir J., Bredesen D.E. Paraptosis: mediation by MAP kinases and inhibition by AIP-1/Alix. Cell Death Differ. 2004, 11:1066-1075.
36. Pallet N., Bouvier N., Bendjallabah A., Rabant M., Flinois J.P., Hertig A., Legendre C., Beaune P., Thervet E., Anglicheau D. Cyclosporine-induced endoplasmic reticulum stress triggers tubular phenotypic changes and death. Am. J. Transplant. 2008, 8:2283-2296.
37. Bouvier N., Flinois J.P., Gilleron J., Sauvage F.L., Legendre C., Beaune P., Thervet E., Anglicheau D., Pallet N. Cyclosporine triggers endoplasmic reticulum stress in endothelial cells: a role for endothelial phenotypic changes and death. Am. J. Physiol. Renal Physiol. 2009, 296:F160-F169.
38. Du S., Hiramatsu N., Hayakawa K., Kasai A., Okamura M., Huang T., Yao J., Takeda M., Araki I., Sawada N., Paton A.W., Paton J.C., Kitamura M. Suppression of NF-kappaB by cyclosporin a and tacrolimus (FK506) via induction of the C/EBP family: implication for unfolded protein response. J. Immunol. 2009, 182:7201-7211.
39. Kitamura M. Induction of the unfolded protein response by calcineurin inhibitors: a double-edged sword in renal transplantation. Nephrol. Dial. Transplant. 2010, 25:6-9.
40. 2+ uptake by cyclosporin A. Br. J. Pharmacol. 2004, 141:263-268.
41. Nacev B.A., Low W.K., Huang Z., Su T.T., Su Z., Alkuraya H., Kasuga D., Sun W., Trager M., Braun M., Fischer G., Zhang K., Liu J.O. A calcineurin-independent mechanism of angiogenesis inhibition by a nonimmunosuppressive cyclosporin A analog. J. Pharmacol. Exp. Ther. 2011, 338:466-475.
42. Bernasconi R., Solda T., Galli C., Pertel T., Luban J., Molinari M. Cyclosporine A-sensitive, cyclophilin B-dependent endoplasmic reticulum-associated degradation. PLoS One 2010, 5.
43. Wang P., Heitman J. The cyclophilins. Genome Biol. 2005, 6:226.
44. Lee J., Choi T.G., Ha J., Kim S.S. Cyclosporine A suppresses immunoglobulin G biosynthesis via inhibition of cyclophilin B in murine hybridomas and B cells. Int. Immunopharmacol. 2012, 12:42-49.
45. 2+ homeostasis after ER stress. J. Cell Sci. 2008, 121:3636-3648.
46. Nakahara C., Nakamura K., Yamanaka N., Baba E., Wada M., Matsunaga H., Noshiro H., Tanaka M., Morisaki T., Katano M. Cyclosporin-A enhances docetaxel-induced apoptosis through inhibition of nuclear factor-kappaB activation in human gastric carcinoma cells. Clin. Cancer Res. 2003, 9:5409-5416.
47. Roy M.K., Takenaka M., Kobori M., Nakahara K., Isobe S., Tsushida T. Apoptosis, necrosis and cell proliferation-inhibition by cyclosporine A in U937 cells (a human monocytic cell line). Pharmacol. Res. 2006, 53:293-302.
48. Ying S., Khan L.N., Meng Q., Barnes N.C., Kay A.B. Cyclosporin A, apoptosis of BAL T-cells and expression of Bcl-2 in asthmatics. Eur. Respir. J. 2003, 22:207-212.
49. Healy E., Dempsey M., Lally C., Ryan M.P. Apoptosis and necrosis: mechanisms of cell death induced by cyclosporine A in a renal proximal tubular cell line. Kidney Int. 1998, 54:1955-1966.
50. Dempsey M., Healy E., Ryan M.P. Intracellular signalling and cyclosporin A-induced apoptosis in a renal cell line. Biochem. Soc. Trans. 1998, 26:S344.
51. Sato M., Tsujino I., Fukunaga M., Mizumura K., Gon Y., Takahashi N., Hashimoto S. Cyclosporine A induces apoptosis of human lung adenocarcinoma cells via caspase-dependent pathway. Anticancer Res. 2011, 31:2129-2134.
52. McDonald J.W., Goldberg M.P., Gwag B.J., Chi S.I., Choi D.W. Cyclosporine induces neuronal apoptosis and selective oligodendrocyte death in cortical cultures. Ann. Neurol. 1996, 40:750-758.
53. Oh Y.L., Han S.Y., Mun K.H., Choi H.J., Kim H.Y., Hwang E.A., Park S.B., Kim H.C., Chang E.J. Cyclosporine-induced apoptosis in osteosarcoma cells. Transplant. Proc. 2006, 38:2237-2239.
54. Tabas I., Ron D. Integrating the mechanisms of apoptosis induced by endoplasmic reticulum stress. Nat. Cell Biol. 2011, 13:184-190.
55. Yoo Y.M., Jeung E.B. Melatonin suppresses cyclosporine A-induced autophagy in rat pituitary GH3 cells. J. Pineal Res. 2010, 48:204-211.
56. Ciechomska I.A., Gabrusiewicz K., Szczepankiewicz A.A., Kaminska B. Endoplasmic reticulum stress triggers autophagy in malignant glioma cells undergoing cyclosporine A-induced cell death. Oncogene 2013, 32:1518-1529.
57. Fu Y., Li J., Lee A.S. GRP78/BiP inhibits endoplasmic reticulum BIK and protects human breast cancer cells against estrogen starvation-induced apoptosis. Cancer Res. 2007, 67:3734-3740.
58. Zinszner H., Kuroda M., Wang X., Batchvarova N., Lightfoot R.T., Remotti H., Stevens J.L., Ron D. CHOP is implicated in programmed cell death in response to impaired function of the endoplasmic reticulum. Genes Dev. 1998, 12:982-995.
59. Nakayama Y., Endo M., Tsukano H., Mori M., Oike Y., Gotoh T. Molecular mechanisms of the LPS-induced non-apoptotic ER stress-CHOP pathway. J. Biochem. 2010, 147:471-483.
60. Overmeyer J.H., Kaul A., Johnson E.E., Maltese W.A. Active ras triggers death in glioblastoma cells through hyperstimulation of macropinocytosis. Mol. Cancer Res. 2008, 6:965-977.
61. Suarez Y., Gonzalez L., Cuadrado A., Berciano M., Lafarga M., Munoz A., Kahalalide F. A new marine-derived compound, induces oncosis in human prostate and breast cancer cells. Mol. Cancer Ther. 2003, 2:863-872.
62. Yoon M.J., Kang Y.J., Lee J.A., Kim I.Y., Kim M.A., Lee Y.S., Park J.H., Lee B.Y., Kim I.A., Kim H.S., Kim S.A., Yoon A.R., Yun C.O., Kim E.Y., Lee K., Choi K.S. Stronger proteasomal inhibition and higher CHOP induction are responsible for more effective induction of paraptosis by dimethoxycurcumin than curcumin. Cell Death Dis. 2014, 5:e1112.
63. Pallet N., Thervet E., Anglicheau D. c-Jun-N-terminal kinase signaling is involved in cyclosporine-induced epithelial phenotypic changes. Am. J. Transplant. 2012, 2012:348604.